The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Practice for the pharmaceutical ...
The move to make pharma more transparent and build a positive reputation is the key theme to come out of the launch of the new ABPI Code of Practice during Code Awareness Week. The move to make pharma ...
Novartis, Pfizer, Otsuka and Novo Nordisk have been called out by the UK’s Prescription Medicines Code of Practice Authority (PMCPA) for breaching the Association of the British Pharmaceutical ...
The new version of the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, which takes effect on July 1, requires drugmakers to provide more details about their relationships ...
More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...
In a guest blog, the ABPI's Esteban Herrero-Martinez explains what changes to European pharmacovigilance legislation mean for ABPI members The healthcare industry uses digital media for a number of ...
ABPI’s recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content ...
Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...
LONDON, March 16 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for two years over what the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback